The Agency of Uzbekistan for the Development of Medical and Pharmaceutical Industry held negotiations with the company Beyond Health regarding potential investment projects aimed at establishing local production of peptide-based medicines.
The Agency's Director, Abdullah Azizov, met with company representatives Farhod Shagulamov and Jan Sebastian Herman to discuss prospects for cooperation in the country's pharmaceutical sector.
During the discussions, potential investment initiatives were reviewed, as well as issues concerning the improvement of the regulatory framework governing pharmaceutical activities in Uzbekistan.
Key Discussion Areas
Particular attention was paid to the implementation of international Good Manufacturing Practice (GMP) standards, drug registration and licensing procedures, as well as the development of domestic pharmaceutical production and increasing the industry's export potential.
The meeting participants also closely examined the practical aspects of the proposed investments in peptide drug production, including the conditions necessary for implementing such projects. The meeting focused on defining areas of possible interaction and assessing opportunities for developing pharmaceutical manufacturing in Uzbekistan.